• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEUROPACE, INC. NEUROPACE RNS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEUROPACE, INC. NEUROPACE RNS SYSTEM Back to Search Results
Model Number RNS-300M-K
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Unspecified Infection (1930)
Event Date 03/16/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).Patient initially implanted on (b)(6) 2017.Patient was implants with the rns system including the device and three leads.Two depth leads (dl-344 (sn (b)(4), port 1, left mesial temporal), dl-344, (sn (b)(4), port 2, right mesial temporal), cl-325 (sn (b)(4), not connected, left temporal (non mesial)).Continued use.
 
Event Description
The site reported - patient has increased serosanguinous weeping from her incision.Patient has had chills and feels somewhat achy.Patient has had intermittent fevers and is regularly taking acetaminophen and ibuprofen daily as needed for incision pain/headaches.At follow up appointment (b)(6) 2017 able to express a very tiny amount of yellowish discharge and there is very tiny pustule along side her incision.At the parietal/occipital area where the circular scab is below the eschar, the circular scab is falling off.There is a palpable enlarged tender lymph node in the right occipital area and also in the left occipital area - in comparison to (b)(6) 2017, these lymph nodes are more prominent and appear tender on palpation.Patient has good mobility of neck without discomfort.There is very mild right cheek swelling and a very mild amount of swelling above right eye - no rash noted.Treatment included: icloxacillin 500 mg bid- 6 week course.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
(b)(4).On (b)(6) "217" neuropace received notification from the site coordinator indicating the patient would be explanted the following day "due to the course of antibiotic treatment being ineffective." on (b)(6) 2017 neurostimulator and leads were explanted.Remote monitor was not returned.Neuropace was informed that the site may consider re-implanting the patient after the infection is resolved.On(b)(6) 2017 the explanted product was returned to neuropace for investigation.The product received included the neurostimulator, connector cover, strain relief, ferrule, ferrule clamp, three leads (one cortical strip and two depth leads) and a section of bone.There is no evidence of product failure/malfunction.Review of the dhr showed no evidence of factors that could have caused or contributed to the reported event.
 
Event Description
New information available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROPACE RNS SYSTEM
Type of Device
NEUROPACE RNS SYSTEM
Manufacturer (Section D)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer (Section G)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer Contact
ramona gonis
455 n. bernardo ave.
mountain view, CA 94043
6502382788
MDR Report Key6481111
MDR Text Key72392368
Report Number3004426659-2017-00014
Device Sequence Number1
Product Code PFN
UDI-Device Identifier00855547005120
UDI-Public010085554700512017170703
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100026
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 06/30/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberRNS-300M-K
Device Catalogue Number1007603
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/16/2017
Initial Date FDA Received04/11/2017
Supplement Dates Manufacturer Received06/05/2017
06/05/2017
Supplement Dates FDA Received06/30/2017
07/25/2017
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age49 YR
-
-